Solventum Corporation (SOLV)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for SOLV is $88.90, 3.6% above the last close of $85.81 on Oct 16, 2026; targets range from $43.51 to $107.17. Rating consensus: Hold.
Snapshot
- P/E10.5x
- P/E vs sector-62.8%
- P/E vs own+20.6%
- Target upside+3.6%
- ConsensusHold
- Market cap$14.61B
- FCF yield-0.8%
- InsidersNone in 90d
- Earnings in20d
- News0.00
Why it moved
Solventum Corporation (SOLV) fell 2.3% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to SOLV.
0 stories on the day (30-day average 0.4).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $85.81 · +20.1% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▼ 50▼ 100▲ 200▲
- Above MAs2 of 4 above
- MA20×50Death 7d ago
- RSI42
- Support-3.8%
- Resistance+1.4%
- Off 52w high-7.2%
- Off ATH-7.2%
- 52w range$85.81
- Bollingerlower half
- MACD-0.14
- ATR+2.6%
- Volume1.3x
Analyst price targets
9 firms with a target in the last 12 months · last close $85.81 · as of Oct 16, 2026
Strong buy 1 · Buy 7 · Hold 5 · Sell 1 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +2.2% year over year, free cash flow 6.5% of revenue, operating margin 8.2%.
| Q2 FY2026 | Jun 30, 2026 | $2.21B | 0.53 | $144M | 58.2% | 8.2% | 4.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.01B | 0.07 | -$273M | 54.7% | 4.0% | 0.6% |
| Q4 FY2025 | Dec 31, 2025 | $2B | 0.37 | $32M | 49.3% | 84.0% | 3.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.1B | 7.22 | -$21M | 56.2% | 6.5% | 60.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.16B | 0.51 | $59M | 54.4% | 9.9% | 4.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.07B | 0.78 | -$80M | 53.8% | 7.3% | 6.6% |
| Q4 FY2024 | Dec 31, 2024 | $2.08B | 0.18 | $92M | 53.9% | 6.6% | 1.5% |
| Q3 FY2024 | Sep 30, 2024 | $2.08B | 0.70 | $76M | 56.0% | 13.2% | 5.9% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $426.70 | -0.3% | -28.0% | +12.1% | 48.5 | $151B | |
| 2 |  | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 3 |  | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | |
| 4 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 5 | | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B | |
| 6 |  | $300.15 | -2.0% | -3.4% | +3.1% | — | $14.46B | |
| 7 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 8 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.